Immuron

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum.

CEO

Steven Lydeamore

CEOSteven Lydeamore

Employees

—

Employees—

Headquarters

Blackburn North, Victoria (VIC)

HeadquartersBlackburn North, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRN Key Statistics

Market cap

12.10M

Market cap12.10M

Price-Earnings ratio

-2.06

Price-Earnings ratio-2.06

Dividend yield

—

Dividend yield—

Average volume

73.43K

Average volume73.43K

High today

$1.79

High today$1.79

Low today

$1.75

Low today$1.75

Open price

$1.78

Open price$1.78

Volume

12.58K

Volume12.58K

52 Week high

$2.87

52 Week high$2.87

52 Week low

$1.50

52 Week low$1.50

IMRN News

TipRanks 10h

Immuron enters partnership with InvestorHub

Immuron (IMRN) advises it has entered into a partnership with InvestorHub, a direct-to-investor engagement software company that provides public companies the d...

TipRanks 2d

Immuron Enhances Investor Engagement with New Interactive Hub

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...